Primitive neuroectodermal tumor: rare, highly aggressive differential diagnosis in urologic malignancies
Jörg Ellinger1, Patrick J Bastian, Stefan Hauser
1Klinik und Poliklinik für Urologie, Universitätsklinikum Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Urology
|August 15, 2006
Summary
Peripheral primitive neuroectodermal tumors (PNETs) are aggressive cancers in young adults. Palpable tumors and synaptophysin expression indicate a poor prognosis for renal PNET.
Area of Science:
- Urologic Oncology
- Pediatric Oncology
- Medical Oncology
Background:
- Peripheral primitive neuroectodermal tumor (PNET) is an aggressive neoplasm within the Ewing sarcoma family of tumors.
- PNET is characterized by specific neural markers and the EWS-FLI1 translocation.
Observation:
- PNET commonly affects young adults, with renal PNET diagnosed at a median age of 24.
- Patients often present with pain, palpable masses, and hematuria, but radiologic findings are non-specific.
- Both renal and bladder PNET are frequently diagnosed at advanced stages.
Findings:
- Histologic and immunohistochemistry findings are crucial for diagnosis.
- Palpable tumor masses and synaptophysin expression are unfavorable prognostic markers for renal PNET.
- Despite aggressive multimodal treatment, the prognosis for PNET remains poor, especially with distant metastases.
Implications:
- Early consideration of PNET in young patients with the classic triad of renal cancer symptoms is vital.
- Prompt initiation of multimodal treatment, including surgery, chemotherapy, and radiotherapy, is essential upon diagnosis.
- Identifying unfavorable prognostic markers aids in risk stratification and treatment planning for PNET patients.